MOMO'S BREAKOUT BOARD

[Kronborg]

VSHC..A non paid tout just came in with this!>>>>>>

As the weekend comes to a close, we wanted to take this chance to update you on some significant revenue numbers released by VSHC. As a penny stock trader, it can be a significant challenge to find revenue generating companies which are under the radar of the broad market, are undervalued, and which represent significant future growth potential. VSHC’s recent press release proves this is just the company we are all looking for. From a technical aspect, the stock is on the verge of a significant move as it is extremely oversold and has been testing the 50 day moving average on heavy bidding. As traders continue to accumulate we could see a major move north. Keep a close eye on this one as the float is small and can deliver explosive gains. Below you can find the recent revenue guidance from the company. As always, see you in the green!

VisualMED Provides Revenue Guidance on First Quarter


RENO, NV–(Marketwire -10/18/11)- VisualMED Clinical Solutions Corp. (The "Company") (Pinksheets: VMCS.PK - News) (Frankfurt: VA6) is pleased to be able to announce today that it expects revenues for the first quarter of fiscal 2012 to be between $320,000 and $400,000. The mid-range of the current guidance would represent close to a 400% increase over the same period last year. The continued growth in revenue reflects the emerging trend away from engineering service companies to medical based vendors with real clinical solutions like those offered by VisualMED. If the first quarter performance trend is maintained in following quarters which are seasonally stronger, then the Company's previous guidance for fiscal 2012 would have to be revised sharply upward.

"It should be remembered that medical informatics is still quasi-virgin territory. We have major business initiatives that have taken long years to develop and are expected to mature this year and start producing revenues," says Chairman Gerard Dab. "Certain contract negotiations have extremely long cycles due to size and complexity of the decision process. Any one of them would have an instant multiplier effect on our performance."

The Company's main priority currently is to finalize certain deals that would see VisualMED medical content powering healthcare applications distributed over a wide array of national institutions in the United States, to hundreds of thousands of users caring for millions of patients. VisualMED advanced solutions, already among the lightest and most flexible in the industry, have been targeted by a number of provider-user partnerships as a likely candidate. This validates once more VisualMED's expertise and ability to leverage its established brand into major corporate relationships.

The Company continues to credit changing conditions in the healthcare market for its continuing performance.




Respectfully,

AB Team

Askblasters.com is not a registered securities broker dealer, in any states, or a registered advisor with the U.S. Securities and Exchange Commission (the SEC.) Information contained by askblasters.com is considered advertisement and intended for informational purpose only. Always consult the advice of a registered representative and consider all the risks involved when investing in stocks. askblasters.com will not guarantee any performance on the companies featured and we assume no liability in such investments. Any information containing “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities of 1934, can be considered unreliable, due to the known and unknown risks and uncertainties outside of our control, where material results can differ. Investments should be made with careful research and full due diligence by visiting the SEC website at http://www.sec.gov for company information. askblasters.com will not be liable for any information contained by askblasters.com resulting in any gains or losses of a featured security and all featured company information should be verified by independent research and a registered licensed consultant. Information contained from the featured companies is deemed reliable but we cannot guarantee the accuracy of the information provided. At times we may hold positions in featured companies and can increase or decrease positions at any given moment without notice.







VSHC, our first healthcare pick and one ready to climb


Dear AB Members, AskBlasters brings to your our first healthcare pick and one ready to increase your portfolio’s value and diversity. VSHC is an extremely undervalued stock and well under all radars, which provides a perfect entry point. Based on their intellectual property, current contracts and size of their OS the fair value for this stock is 0.10 cents and offers a 733% to 1466% potential return on your investment. VSHC recently bounced off both its 100-day-moving average (MA) and its 200MA, while finding support at its 50MA. The stock literally moved on air, as little to no buying on the offer forced market makers to increase the price per share in order to find the balance between supply and demand. The company also has big announces to make in the coming weeks as it sets it itself to become the leader in healthcare informatics. we wish everyone the best in your investment / trade.







Visual Healthcare Corp.

A Healthcare Information Technology Company



Visual Healthcare Corp. is an information technology company that designs, creates and develops state-of-the-art information platforms specifically conceived for the automation of of health care information management and the needs of health care organizations.

The Company owns an extensive portfolio of proprietary technologies used in the fields of medicine, hospital management, data security, and healthcare infrastructure. It licenses its technology to operating companies in exchange for an equity stake or a royalty stream.It owns a significant stake in VisualMED Clinical Solutions Corp, a medical software company listed on both the NASDQ and Frankfurt exchanges.

Our core enabling platform supports a wide range of medical and pharmaceutical applications some of which uniquely suited to help automate the delivery of medical attention at point of care in a variety of settings from ambulatory to tertiary care.

We power smart HER applications and Clinical Information Systems (CIS) built to conform to the way doctors and nurses provide and document patient care. Our platform is one of the few to have been designed and maintained by practicing medical staff from a world leading medical school. It has a particularly strong focus on professional workflow management for medical facilities and pharmacy settings.

State-of-the art design and object-oriented design and table-driven programming allows for cost-effective development that can rapidly respond to advances in medicine and surgery and informatics.




Company Highlights









Visual Healthcare Corp., since 1998, designs, creates and develops innovative information platforms, specifically conceived for the automation of a wide range of scientific disciplines. These include pharmaceutical research, clinical trials, laboratory automation, true quality assurance tools, total quality control applications, and quantitative analytic tools such as proprietary frameworks for electronic health records, electronic prescription, infection and disease control, and smart cancer registries.




The company’s extensive portfolio of proprietary technologies is the result of a unique collaboration between senior clinicians from the McGill University Faculty of Medicine and affiliated tertiary care centers, medical software architects, and a Fortune 100 healthcare service company, investing some $50 million in the process. The Company licenses its technology to operating companies in exchange for an equity stake or a royalty stream. It owns significant stakes in various companies including VisualMED Clinical Solutions Corp. (NASDAQ OTC: VMCS), a leader in the field of electronic health records.




Company Platforms




Visual Healthcare core transactional IT platform has at its center an inference engine with tens of thousands of decisional algorithms that can analyze data to a depth of 49 levels. Visual Healthcare additionally has developed proprietary platforms for research and development in the pharmaceutical industry.

We are the sole owners of all intellectual property rights to all platforms, inference engines, software, modules and applications that we have designed and paid for over the years. Our software maintenance and development is being contracted to third party strategic partners and contract software houses. We control planning, architecture and quality assurance in all development work.




Pharmaceutical Platform

Our complete Pharmaceutical Platform is designed to streamline core pharmaceutical information management and correlational activities:

Clinical Trials

Centralized information management

Powerful inference engine and basic decision support technology brought to bear on cohort analysis and identification

Real-time communication and instant input recognition across entire database




Insurance Management

Increased data pool for results-powered risk assessment

Increased quality assurance for key factor identification and effective model distribution

Epidemiology & Disease Control

Visual Healthcare disease registry can track the progress of diseases and establish origination patterns based on proprietary data mining techniques.

The disease registry is a data system that collects, manages, and analyzes data about specific cases and deaths. Various medical facilities (including hospitals, physicians' offices, therapeutic facilities, freestanding surgical centers, and pathology laboratories) report data to a central cancer registry which exists in most American states and some Canadian provinces, and information for a disease registry may be collated in the same way.




The use of registries is a relatively recent event and prior to their advent in the United States and Canada; data regarding cancer statistics were often unknown or misrepresented.




Our registry does the following:







-Monitors trends over time. -Determines patterns in various populations. -Guide planning and evaluation of control programs (e.g., determine whether prevention, screening, and treatment efforts are making a difference). -Help set priorities for allocating health resources. Provincial and federal governments depend on data provided by health providers to allocate resources. With incomplete data comes under funding at the source. Thus improvements in data collection will inevitably lead to better distribution of resources and potentially improvement in care. -Advance clinical, epidemiologic, and health services research. -Potentially provide information for a national database of disease incidence. – help to assess the impact of prevention and control efforts – respond to reports of suspec ted increases in occurrence -help to compare the patterns of care that patients receive.




Chronic Care

New web based software platforms we have been developing will have the capacity to enable flexible, light applications to help physicians bring down the cost of following patients suffering from chronic conditions. A new generation of efficiency applications will have to be deployed if U.S. health costs are to be contained, ranging from elimination of duplication to better home care monitoring of seniors.

Many different disease management programs attempted over the past two decades have been unsuccessful in trying to help providers and caregivers manage conditions which affect large sections of the population in a chronic, systematic fashion. Management of chronic illness has long been thought to benefit from information database technology, as recent studies show that chronic illness treatment may constitute up to three quarters of healthcare budgets.

Homecare Monitoring

Visual Healthcare can monitor patients at a distance, allowing care teams to keep tabs on patients who require constant supervision, particularly chronic illnesses, where patients can be treated at home and need not unnecessarily burden a facility as in-patients, nor carry the associated costs of being hospitalized.

This platform is particularly useful in monitoring non-acute rehabilitation and convalescence patients, whose condition may be monitored by physicians remotely.

Quality Assurance & Risk Management

All Visual Healthcare platforms allow for facilities to establish site-specific protocols as set by local administration, allowing systems to be tailored to regional regulations, mandates and customs and practices.

All transactions within a Visual Healthcare system is automatically logged and recorded for future quality control audit, thus allowing facilities to better establish risk policies, manage them, and present accurate data, particularly where insurance concerns are primary.

R&D / Lab Automation

Visual Healthcare allows seamless flow of information in real-time, ideal for research and development activities where various teams need informed and concurrent access to pools of data.

Additionally, as a medical encyclopedia with powerful inference engine, tens of thousands of algorithms, including a full set of drug-drug interaction algorithms, Visual Healthcare can not only be instrumental in Laboratory automation, but in the transition to ‘smart’ labs.




Industry Background









Our industry can be defined by the following market markers: 10,000 medical facilities in the US, one million physicians, thousands of clinical trials, of which no more than 2% use information technology to drive efficiency and control cost. As opposed to practically every other industries health care delivery has not embraced automation and standardization. However new federal legislation in the United States and abroad, reflecting a shift in public policy with regard to healthcare information technology (IT), has begun to favor the widespread deployment of IT solutions in the healthcare field. We expect to benefit from both public policy but also from the considerable monies that will be spent in the coming years.




Recent Developments

Modern hospitals are under increasing pressure to address mounting evidence of major increases in hospital death due to medical errors and ADEs. According to recent publications the number of Americans who die each year from adverse Drug Event may be as much as three hundred thousand or says Newsweek Magazine, the equivalent of a jumbo jet crashing three times a week.

A coalition of some of America’s largest employers and healthcare purchasers helped to create the Leapfrog Group, a nonprofit organization dedicated to promoting information solutions for hospitals. According to the Leapfrog Group, CPOE systems with clinical decision support are deemed to be the core component of an effective clinical information system to replace paper-based records. The Obama administration is now moving to enforce standards similar to the leapfrog Recommendations. The current Economic Stimulus package, The American Recovery and Reinvestment Act, ARRA, contains important provisions and appropriations to promote a major overhaul of the country’s healthcare system. Included are some $36 Billion earmarked for physicians and hospitals that have not yet adopted Electronic H ealth Records.

Much of these funds are tied to incentive programs funding physicians and facilities with elevated Medicaid patient flow and with Medicare acceptance.

There is a sense of urgency to promote fast development of these programs, and so incentive programs are heavily front-loaded. There is a 5-year window for applicants to receive funding from the program beginning in 2011. Those that file as of the first available opportunity in the first year, however, stand to receive a significantly larger share of the incentive budget.

The underlying principles and application standards will be rolled out by HHS throughout the launching period of the program and all the rules will have to be properly understood.




Company Leadership




Principals

Gerard Dab, the Company’s founder, has been Chairman and CEO since inception in 1998. Mr. Dab holds an Honors BA and an MA from McGill University. After an academic career and serving as an executive with advertising company Foote, Cone & Belding of Chicago, he served as president of Productions Publi-Cité Inc. of Montreal, a film and television finance company, from November 1982 to June 1992. From June 1992 to April 1998, Mr. Dab was executive producer of “Finance,” a weekly television program on Canada’s TVA network. Mr. Dab is currently Chairman and CEO of affiliate VisualMED Clinical Solutions Corp. (vmcs.pk).






Board of Directors

Mr. Gerard Dab, Chairman, CEO Ms. Celine Kuyumcu, Director Mr. Real Gauthier, Director




Contact Info

Visual Healthcare Corp. 50 West Liberty Street, Suite 880 Reno, Nevada 89501 Tel. [phone]

Email: [e-mail]

For technical information: Fred Berlin Director – Technical Services Tel. [phone]

Email: [e-mail]